NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation

Z Wang, G Xu, Z Li, X Xiao, J Tang… - Journal of Inflammation …, 2022 - Taylor & Francis
Inflammation is the tissues' defense response after the body is stimulated by microbial
infection or damage signals, and it is initiated when pattern recognition receptors recognize …

Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases

N Özenver, T Efferth - Pharmacological research, 2021 - Elsevier
The NLRP3 inflammasome holds a crucial role in innate immune responses. Pathogen-and
danger-associated molecular patterns may initiate inflammasome activation and following …

Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation

H Honda, Y Nagai, T Matsunaga… - Journal of leukocyte …, 2014 - academic.oup.com
Inflammasome activation initiates the development of many inflammatory diseases,
including obesity and type 2 diabetes. Therefore, agents that target discrete activation steps …

Therapeutic targeting of NLRP3 inflammasomes by natural products and pharmaceuticals: a novel mechanistic approach for inflammatory diseases

S Jahan, D Kumar, S Chaturvedi… - Current medicinal …, 2017 - ingentaconnect.com
Inflammasomes are multiprotein complexes having nucleotide-binding domain and leucine-
rich repeat consisting members along with pyrin and HIN domain family. An inflammasome …

Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome

M Bagherniya, H Khedmatgozar… - Phytotherapy …, 2021 - Wiley Online Library
The NLR family, pyrin domain‐containing 3 (NLRP3) inflammasome is a multiprotein
complex that induces caspase‐1 activation and the downstream substrates involved with the …

Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly

Y Shi, H Wang, M Zheng, W Xu, Y Yang… - The FASEB …, 2020 - Wiley Online Library
Ginsenoside Rg3 is one of the main constituents of Panax ginseng. Compelling evidence
has demonstrated that ginsenoside Rg3 is capable of inhibiting inflammation. However, the …

Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3‐driven inflammatory diseases in mice

W Li, H Xu, J Shao, J Chen, Y Lin… - British journal of …, 2023 - Wiley Online Library
Background and Purpose The NLR family pyrin domain‐containing 3 (NLRP3)
inflammasome is activated in many inflammatory conditions. So far, no low MW compounds …

[HTML][HTML] Targeting NLRP3 inflammasome in the treatment of diabetes and diabetic complications: Role of natural compounds from herbal medicine

Y Bai, Q Mu, X Bao, J Zuo, X Fang, J Hua… - Aging and …, 2021 - ncbi.nlm.nih.gov
Diabetes, a common metabolic disease with various complications, is becoming a serious
global health pandemic. So far there are many approaches in the management of diabetes; …

Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023

M Duan, L Sun, X He, Z Wang, Y Hou, Y Zhao - European Journal of …, 2023 - Elsevier
Nod-like receptor protein 3 (NLRP3), a therapeutic target that has a close relationship with
inflammatory diseases, has drawn significant attention from researchers in the field. An …

Natural products that target the NLRP3 inflammasome to treat fibrosis

N Ding, B Wei, X Fu, C Wang, Y Wu - Frontiers in pharmacology, 2020 - frontiersin.org
Fibrosis is a common pathway followed by different organs after injury, and it can lead to
parenchymal scarring, cellular dysfunction, and even organ failure. The NLRP3 …